Hepatitis
HBsAg ELISA 4.0 (RUO)
The HBsAg ELISA 4.0 is an enzyme-linked immunosorbent assay (ELISA) intended for the detection of hepatitis B virus surface antigen (HBsAg) in human serum or plasma samples. For research purposes only, not for use in the diagnosis or prognosis of disease.
Anti-HBs ELISA 4.0 (RUO)
The Anti-HBs ELISA 4.0 is an enzyme linked immunosorbent assay (ELISA) for in vitro qualitative detection of antibodies to hepatitis B virus surface antigen (anti-HBs) in human serum or plasma. For research use only, not for use in the diagnosis or prognosis of disease.
Anti-HBs ELISA 4.0
The Anti-HBs ELISA 4.0 is an enzyme-linked immunosorbent assay (ELISA) intended for the detection of antibodies to hepatitis B virus surface antigen (anti-HBs) in human serum or plasma samples.
Anti-HBe ELISA 4.0 (RUO)
The Anti-HBe ELISA 4.0 is an enzymelinked immunosorbent assay (ELISA) for qualitative detection of hepatitis B virus e antigen (Anti-HBe) in human serum or plasma. For research use only, not for use in the diagnosis or prognosis of disease.
Anti-HBe ELISA 4.0
The Anti-HBe ELISA 4.0 is an enzyme-linked immunosorbent assay (ELISA) intended for the detection of antibodies to hepatitis B virus e Antigen (HBeAg) in human serum or plasma samples.
HBsAg ELISA 4.0
The HBsAg ELISA 4.0 is an enzyme-linked immunosorbent assay (ELISA) intended for the detection of hepatitis B surface antigen (HBsAg) in human serum or plasma samples.
HBsAg ELISA 4.1 (CE)
The HBsAg ELISA 4.1 is an enzymelinked immunosorbent assay (ELISA) intended for qualitative detection of hepatitis B virus surface antigen in human serum or plasma. Kit is intended for screening of blood donors and for diagnosing of patients related to infection with hepatitis B virus.
HBeAg ELISA 4.0
The MPD HBeAg ELISA 4.0 is a double antibody sandwich immunoassay that utilises monoclonal antibodies specific to hepatitis B virus e antigen.
HAV IgM ELISA 4.0 (RUO)
The HAV IgM ELISA 4.0 is an enzyme-linked immunosorbent assay (ELISA) intended for the detection of IgM antibodies to hepatitis A virus (HAV) in human serum or plasma samples.